GTCbio's 3rd Assay Development and Screening Technologies [4] conference on June 5-6, 2008 in San Francisco, CA will provide attendees with critical information to utilize in the discovery and development of assays, while keeping them informed about the latest screening technologies for both high-throughput screening and high-content screening.
Hear from leading researchers developing and using assays to advance their discovery pipelines. Register today to network with top industry representatives!
Submit an Abstract [5] by May 5, 2008
Register [6] by April 5, 2008 for a 20% DISCOUNT
Program Highlights:
Cell Based Assays Part I - High Throughput Screening
Cell Based Assays Part II - High Content Screening
In Vitro Assays and Screening
Novel Assay and Screening Technologies
Target Validation and Assay Development
Informatics – Data and Sample Collection & Management
Register [8] 2, the 3rd person goes free!
Visit www.gtcbio.com [9] or call 626-256-6405 for details.
Keynote Speakers:
Robert Hertzberg, Ph.D.
Vice President, Screening & Compound Profiling
GlaxoSmithKline
Berta Strulovici, Ph.D.
Vice President, Basic Research MRL, Automated Biotechnology Head
Merck & Co.
Christopher P. Austin, Ph.D.
Director, NHGRI;
Senior Advisor for Translational Research, Office of the Director
National Human Genome Research Institute, NIH
Presenting Organizations:
Gautam Agnihotri, New Lead Discovery, Schering-Plough
Jeremy Caldwell, Executive Director, Molecular and Cell Biology
Genomics Institute of the Novartis Research Foundation
John Cuozzo, Director, Lead Discovery, GlaxoSmithKline
Hakim Djaballah, Director, HTS Core Facility Head, Memorial Sloan Kettering Cancer Center
Paul Lang, Head of Assay Development and Biomolecular Pharmacology, Merck Serono Pharmaceutical Research Institute
Yaya Liu, Ph.D., Research Investigator, Abbott Laboratories
David Mark, Head of Screening Technologies, Roche
Y. Gloria Meng, Technology, Genentech
Matthew Olson, Johnson & Johnson
Gary Piazza, Molecular Libraries Screening Center, Southern Research Institute
Clay Scott, Associate Director, Lead Generation Dept., AstraZeneca
Theingi Thway, Ph.D., Pharmacokinetics & Drug Metabolism, Amgen
Hong Xin, Ph.D., Lead Generation, Johnson & Johnson
And more! Click here [10] for a full speakers list.
20% DISCOUNT DEADLINE: April 5, 2008
Abstract Deadline: May 5, 2008. Click here [11] to submit an abstract.
For More information visit www.gtcbio.com [12] or call 626-256-6405.